Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation.

about

Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation.

Item

http://www.wikidata.org/entity/Q41302280

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Management of pulmonary hypert ...... hotopic heart transplantation.

@en

type

Item

label

Management of pulmonary hypert ...... hotopic heart transplantation.

@en

prefLabel

Management of pulmonary hypert ...... hotopic heart transplantation.

@en

P1476

Management of pulmonary hypert ...... hotopic heart transplantation.

@en

P2093

Alan L Gass

http://www.w3.org/2001/XMLSchema#string

Anna Koulova

http://www.w3.org/2001/XMLSchema#string

Chhaya Aggarwal Gupta

http://www.w3.org/2001/XMLSchema#string

Gregg M Lanier

http://www.w3.org/2001/XMLSchema#string

Saikrishna Patibandla

http://www.w3.org/2001/XMLSchema#string

Wilbert S Aronow

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease.

Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME

The immediate effect of sildenafil on right ventricular function in patients with heart failure measured by cardiac magnetic resonance: a randomized control trial

Inhaled iloprost for severe pulmonary hypertension.

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation.

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

P304

2640-2649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2017.07.24

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28932571

http://www.w3.org/2001/XMLSchema#string

P932

5594194

http://www.w3.org/2001/XMLSchema#string